Carla Eymard has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Probing the Chemical Space of Polymerase Theta with Nucleotide Analogues Bearing a Stereogenic All-Carbon Quaternary Center

    by Amarender Manchoju, Nicole M. Duffy, Renaud Zelli, Carla Eymard, Michel Gallant, Alix Genieyz, Marc-Olivier Labbé, Tommy Lussier, Guillaume Michaud, Léa Théroux, et al.

    We report findings on a novel family of nucleotide analogues with selective inhibitory activity against DNA polymerase theta (Polθ), a key enzyme in the theta-mediated end joining pathway and a critical player in synthetic lethality-based cancer therapies. Polθ's intrinsically low fidelity, which contributes to genomic instability in homologous recombination-deficient tumors, was probed for selective targeting by these analogues. The newly identified compounds feature an all-carbon stereogenic quaternary center at either the C3' or C2' position of the furanoside ring, a structural modification that has already demonstrated potential in antiviral, anticancer, and cardioprotective applications. Biochemical assays suggest these analogues exploit Polθ's unique active site architecture, offering a possible direction for overcoming PARP inhibitor resistance and enhancing personalized cancer treatment strategies.


  • A Nucleoside Analogue Bearing a C2′-Stereogenic All-Carbon Quaternary Center for the Treatment of Heart Failure

    by Abir Almazloum, Wael Maharsy, Starr Dostie, Fabiola Becerril-Jiménez, Carla Eymard, Hiba Komati, Louis Leblanc, Amarender Manchoju, Philippe Mochirian, Renaud Zelli, et al.

    Heart failure (HF) is a significant global health burden with a high mortality rate and no curative or preventative treatment. Many factors can contribute to HF development, including hemodynamic factors and chemotherapy-induced cardiotoxicity. Loss of cardiomyocytes triggers cardiac remodeling and HF, suggesting that strategies aimed at preserving cardiomyocyte survival could provide therapeutic benefits. Here, we describe the biological activity of an adenosine-like nucleoside analogue bearing an all-carbon stereogenic quaternary center that induces a conformational bias to enhance both activity and selectivity. The lead compound, LCB-2122, prevents cardiomyocyte death both in vitro and in vivo in an animal model of acute chemotherapy-induced HF. This protective effect against chemotherapy-induced cardiomyocyte loss is linked to AMPK activation and is abrogated by siRNA-mediated reduction of AMPK expression. The results suggest that targeting cardiomyocyte survival with conformationally biased nucleoside analogues may offer a promising avenue for preventing cardiac dysfunction and the progression of HF.

  • Open Access

    Synthesis of 4′-Thionucleoside Analogues Bearing a C2′ Stereogenic All-Carbon Quaternary Center

    by Carla Eymard, Amarender Manchoju, Abir Almazloum, Starr Dostie, Michel Prévost, Mona Nemer, Yvan Guindon

    The design of novel 4′-thionucleoside analogues bearing a C2′ stereogenic all-carbon quaternary center is described. The synthesis involves a highly diastereoselective Mukaiyama aldol reaction, and a diastereoselective radical-based vinyl group transfer to generate the all-carbon stereogenic C2′ center, along with different approaches to control the selectivity of the N-glycosidic bond. Intramolecular SN2-like cyclization of a mixture of acyclic thioaminals provided analogues with a pyrimidine nucleobase. A kinetic bias favoring cyclization of the 1′,2′-anti thioaminal furnished the desired β-D-4′-thionucleoside analogue in a 7:1 ratio. DFT calculations suggest that this kinetic resolution originates from additional steric clash in the SN2-like transition state for 1′,4′-trans isomers, causing a significant decrease in their reaction rate relative to 1′,4′-cis counterparts. N-glycosylation of cyclic glycosyl donors with a purine nucleobase enabled the formation of novel 2-chloroadenine 4′-thionucleoside analogues. These proprietary molecules and other derivatives are currently being evaluated both in vitro and in vivo to establish their biological profiles.


  • Open Access

    Nucleotide Analogues Bearing a C2′ or C3′-Stereogenic All-Carbon Quaternary Center as SARS-CoV-2 RdRp Inhibitors

    by Amarender Manchoju, Renaud Zelli, Gang Wang, Carla Eymard, Adrian Oo, Mona Nemer, Michel Prévost, Baek Kim, Yvan Guindon

    The design of novel nucleoside triphosphate (NTP) analogues bearing an all-carbon quaternary center at C2′ or C3′ is described. The construction of this all-carbon stereogenic center involves the use of an intramoleculer photoredox-catalyzed reaction. The nucleoside analogues (NA) hydroxyl functional group at C2′ was generated by diastereoselective epoxidation. In addition, highly enantioselective and diastereoselective Mukaiyama aldol reactions, diastereoselective N-glycosylations and regioselective triphosphorylation reactions were employed to synthesize the novel NTPs. Two of these compounds are inhibitors of the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, the causal virus of COVID-19.


  • Photoredox-Catalyzed Stereoselective Radical Reactions to Synthesize Nucleoside Analogues with a C2′-Stereogenic All-Carbon Quaternary Center

    by Fabiola Becerril-Jiménez, Tommy Lussier, Louis Leblanc, Carla Eymard, Starr Dostie, Michel Prévost, Yvan Guindon

    The design of novel nucleoside analogues bearing a C2’ all-carbon quaternary center is described. The construction of this all-carbon stereogenic center involves the use of photoredox catalysis to initiate an intramolecular attack of a silyl-tethered vinyl functionality on a tertiary radical. DFT calculations were performed to explore the origin of the high syn diastereoselectivity obtained through the preferred 5-exo-trig cyclization mode. The intramolecular vinyl addition also enables the preparation of the complementary configuration of the C2’ all-carbon stereocenter when performed after lactonization.